ChristianaCare’s Gene Editing Institute says it has found a way to reverse chemotherapy resistance in one of the most common ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

CRISPR gives us the power to rewrite DNA, while AI accelerates that power beyond human control. Together, they’ve launched a genetic arms race that could redefine life—or erase it entirely.

CRISPR Therapeutics' CTX310 trial shows strong, sustained lipid reductions and favorable safety, boosting confidence in its ...

From revolutionary CRISPR treatment to heavy drinking dangers, here's what you need to know about the latest health research.

The company scans entire proteins with CRISPR to find functional vulnerabilities, then hunts for molecules that exploit them ...

Yi Li, professor of horticultural plant breeding biotechnology in the College of Agriculture, Health and Natural Resources ...

Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

The idea that a single-celled bacterium can defend itself against viruses in a similar way as the 1.8-trillion-cell human immune system is still “mind-blowing” for molecular biologist Joshua W. Modell ...

ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the Unstoppable Stocks to Buy and Hold for the Next 5 Years. On September 23, analyst Mitchell Kapoor from H.C. Wainwright reiterated a “Buy” rating on ...